231 related articles for article (PubMed ID: 20947264)
1. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer.
Fleckenstein J; Kühne M; Seegmüller K; Derschang S; Melchior P; Gräber S; Fricke A; Rübe CE; Rübe C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1465-72. PubMed ID: 20947264
[TBL] [Abstract][Full Text] [Related]
2. DNA double-strand break analysis by γ-H2AX foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients.
Goutham HV; Mumbrekar KD; Vadhiraja BM; Fernandes DJ; Sharan K; Kanive Parashiva G; Kapaettu S; Bola Sadashiva SR
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e607-12. PubMed ID: 22836053
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl Sulfoxide Prevents Radiation-Induced Oral Mucositis Through Facilitating DNA Double-Strand Break Repair in Epithelial Stem Cells.
Yang C; Tang H; Wang L; Peng R; Bai F; Shan Y; Yu Z; Zhou P; Cong Y
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1577-1589. PubMed ID: 30092334
[TBL] [Abstract][Full Text] [Related]
4. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
5. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
7. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Hänscheid H; Gassen D; Biko J; Meineke V; Reiners C; Scherthan H
J Nucl Med; 2010 Aug; 51(8):1318-25. PubMed ID: 20660387
[TBL] [Abstract][Full Text] [Related]
8. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
9. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
[TBL] [Abstract][Full Text] [Related]
10. [Early-onset radiation complications and tissue damage in the treatment of head and neck tumors].
Isaev PA; Medvedev VS; Pasov VV; Semin DIu; Derbugov DN; Pol'kin VV; Terekhov OV
Vopr Onkol; 2010; 56(5):552-8. PubMed ID: 21137234
[TBL] [Abstract][Full Text] [Related]
11. Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy.
Lorat Y; Fleckenstein J; Görlinger P; Rübe C; Rübe CE
Strahlenther Onkol; 2020 Sep; 196(9):821-833. PubMed ID: 32006067
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of γ-H2AX during radiotherapy of head and neck cancer potentially allow for prediction of severe mucositis.
Kazmierska J; Barczak W; Winiecki T; Łuczewski Ł; Marciniak M; Suchorska W
Radiol Oncol; 2020 Feb; 54(1):96-102. PubMed ID: 32061167
[TBL] [Abstract][Full Text] [Related]
13. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
15. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
[TBL] [Abstract][Full Text] [Related]
16. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
Wendt TG; Grabenbauer GG; Rödel CM; Thiel HJ; Aydin H; Rohloff R; Wustrow TP; Iro H; Popella C; Schalhorn A
J Clin Oncol; 1998 Apr; 16(4):1318-24. PubMed ID: 9552032
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
Kohno N; Kitahara S; Tamura E; Tanabe T
Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
[TBL] [Abstract][Full Text] [Related]
19. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
[TBL] [Abstract][Full Text] [Related]
20. DNA repair alterations in children with pediatric malignancies: novel opportunities to identify patients at risk for high-grade toxicities.
Rübe CE; Fricke A; Schneider R; Simon K; Kühne M; Fleckenstein J; Gräber S; Graf N; Rübe C
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):359-69. PubMed ID: 20153123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
